back to top
My wish lists
Save your wish list
If you want to add more content to your wish list, simply log in. If you do not have a user account, please register for the Hanser Customer Center.

» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.
Your wish lists
If you want to use your wish list during your next visit, simply log in. If you do not have a user account, please register for the Hanser Customer Center.
» Do you already have a user account? Please log in here.
» Don't have a user account yet? Please register here.

« Back

Your advantages at a glance

  • One login for all Hanser portals
  • Individual home page for faster access to preferred content
  • Exclusive access to selected content
  • Personal wish lists on all portals
  • Central management of your personal information and newsletter subscriptions

Register now
Deutsch
Bookmark Bookmarked
02-18-2011

Solvay: 2010 Results

Annual sales of Solvay amounted to EUR 7,109 million. At constant scope, they improved by 22% both on an annual basis and in the 4th quarter. Annual sales in the Chemicals Sector (EUR 3,012 million) improved by 11%; sales volumes, significantly up (+14%), compensated for the lower sales prices (-6%). Annual sales in the Plastics Sector (EUR 3,784 million) clearly improved (+33% at constant scope), especially thanks to a significant increase in sales volumes in Specialty Polymers (+36% compared to last year). From a geographic standpoint, Asia’s contribution to the Group’s total sales strongly improved, going from 10% in 2009 to 14% in 2010.

The recurring Group operating result (Rebit) amounted to EUR 633 million in 2010. Rebit for continuing activities posted very significant improvement compared to last year, both on a cumulative basis (EUR 602 million, or +94%) and on a quarterly basis (EUR 155 million in the 4th quarter of 2010, or +75%). In addition to the strong increase in sales volumes, it benefited, overall, from significant cost cutting efforts and energy costs that were under control.

The Group’s operating margin (Rebit on sales), excluding the pharmaceuticals activities, was 8.9% in 2010 compared to 5.4% in 2009; it amounted to 9.4% in the 4th quarter of 2010.

The annual net income of the Group reaches EUR 1,823 million. It benefited from the capital gain realized on the sale of the pharmaceutical activities (EUR 1.7 billion) and was negatively impacted by non recurring items for an amount of EUR 328 million.

additional links
Newsletter

Would you like to subscribe to our Newsletters on plastics technology and profit from the latest information?

Subscribe here

Subscribe here

Job Advertisements

Looking for a new challenge? Check out our jobs market!

Job Advertisements

Patents Stimulate Innovation

Patents encourage innovation: Stay on the ball with the latest innovations in the plastics industry in our patents section.

Patents